European biotech revenues up 13% in 2006

Sunday 3 June 2007

The European biotechnology industry increased its revenues by 13% in 2006, while narrowing its losses. At the same time, spending on research and development increased, especially on the part of the 32 companies that made initial public offerings during the year.

Read in full with a subscription

Learn more about subscribing to MedNous.

Subscribe